125I radioimmunoassay for the dual detection of amphetamine and methamphetamine

C. Ward, A. J. McNally, Daniel Rusyniak, S. J. Salamone

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A radioimmunoassay that exhibits a nearly equivalent response to D- amphetamine and D-methamphetamine in urine over the assay range of 0 to 1000 ng/mL while displaying low cross-reactivity to L-amphetamine and L- methamphetamine (4.6% and 2.4%, respectively) has been developed. In addition, methylenedioxy-amphetamine (MDA) and methylenedioxymethamphetamine (MDMA) were detectable in the assay with cross-reactivity levels of >100% and 77% respectively. Little cross-reactivity was observed with the commonly encountered over-the-counter (OTC) drags and this cross-reactivity was further reduced by the addition of sodium periodate into the reaction mixture to oxidize the β-hydroxylamines. The double (second) antibody assay uses 125I-radiolabeled derivatives of both D-amphetamine and D-methamphetamine as tracers in combination with two highly specific sheep antisera directed against D-amphetamine and D-methamphetamine. The assay exhibits a dose response of approximately 90,000 dpm from 0 to 1000 ng/mL of D-amphetamine or D-methamphetamine with a minimum detectable dose for either drag of approximately 25 ng/mL. With a cut-off level of 500 ng/mL, the assay gave a positive result for 100% of the 111 clinical samples containing GC/MS confirmed (at or above the NIDA GC/MS cut-off values) levels of amphetamine and/or methamphetamine. Eighty eight samples that screened negative in a clinical laboratory were all negative in the assay. Nineteen samples which were incorrectly identified as positive by other commercially available amphetamine assays were negative in this RIA.

Original languageEnglish (US)
Pages (from-to)1486-1496
Number of pages11
JournalJournal of Forensic Sciences
Volume39
Issue number6
StatePublished - 1994
Externally publishedYes

Fingerprint

Methamphetamine
Amphetamine
Radioimmunoassay
Hydroxylamines
N-Methyl-3,4-methylenedioxyamphetamine
Values
Immune Sera
Sheep
Urine
Antibodies

Keywords

  • amphetamines
  • detection of drugs
  • RIA
  • toxicology

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Law

Cite this

125I radioimmunoassay for the dual detection of amphetamine and methamphetamine. / Ward, C.; McNally, A. J.; Rusyniak, Daniel; Salamone, S. J.

In: Journal of Forensic Sciences, Vol. 39, No. 6, 1994, p. 1486-1496.

Research output: Contribution to journalArticle

Ward, C. ; McNally, A. J. ; Rusyniak, Daniel ; Salamone, S. J. / 125I radioimmunoassay for the dual detection of amphetamine and methamphetamine. In: Journal of Forensic Sciences. 1994 ; Vol. 39, No. 6. pp. 1486-1496.
@article{9cafd1986af34d3b8d9de6a52c9fe642,
title = "125I radioimmunoassay for the dual detection of amphetamine and methamphetamine",
abstract = "A radioimmunoassay that exhibits a nearly equivalent response to D- amphetamine and D-methamphetamine in urine over the assay range of 0 to 1000 ng/mL while displaying low cross-reactivity to L-amphetamine and L- methamphetamine (4.6{\%} and 2.4{\%}, respectively) has been developed. In addition, methylenedioxy-amphetamine (MDA) and methylenedioxymethamphetamine (MDMA) were detectable in the assay with cross-reactivity levels of >100{\%} and 77{\%} respectively. Little cross-reactivity was observed with the commonly encountered over-the-counter (OTC) drags and this cross-reactivity was further reduced by the addition of sodium periodate into the reaction mixture to oxidize the β-hydroxylamines. The double (second) antibody assay uses 125I-radiolabeled derivatives of both D-amphetamine and D-methamphetamine as tracers in combination with two highly specific sheep antisera directed against D-amphetamine and D-methamphetamine. The assay exhibits a dose response of approximately 90,000 dpm from 0 to 1000 ng/mL of D-amphetamine or D-methamphetamine with a minimum detectable dose for either drag of approximately 25 ng/mL. With a cut-off level of 500 ng/mL, the assay gave a positive result for 100{\%} of the 111 clinical samples containing GC/MS confirmed (at or above the NIDA GC/MS cut-off values) levels of amphetamine and/or methamphetamine. Eighty eight samples that screened negative in a clinical laboratory were all negative in the assay. Nineteen samples which were incorrectly identified as positive by other commercially available amphetamine assays were negative in this RIA.",
keywords = "amphetamines, detection of drugs, RIA, toxicology",
author = "C. Ward and McNally, {A. J.} and Daniel Rusyniak and Salamone, {S. J.}",
year = "1994",
language = "English (US)",
volume = "39",
pages = "1486--1496",
journal = "Journal of Forensic Sciences",
issn = "0022-1198",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - 125I radioimmunoassay for the dual detection of amphetamine and methamphetamine

AU - Ward, C.

AU - McNally, A. J.

AU - Rusyniak, Daniel

AU - Salamone, S. J.

PY - 1994

Y1 - 1994

N2 - A radioimmunoassay that exhibits a nearly equivalent response to D- amphetamine and D-methamphetamine in urine over the assay range of 0 to 1000 ng/mL while displaying low cross-reactivity to L-amphetamine and L- methamphetamine (4.6% and 2.4%, respectively) has been developed. In addition, methylenedioxy-amphetamine (MDA) and methylenedioxymethamphetamine (MDMA) were detectable in the assay with cross-reactivity levels of >100% and 77% respectively. Little cross-reactivity was observed with the commonly encountered over-the-counter (OTC) drags and this cross-reactivity was further reduced by the addition of sodium periodate into the reaction mixture to oxidize the β-hydroxylamines. The double (second) antibody assay uses 125I-radiolabeled derivatives of both D-amphetamine and D-methamphetamine as tracers in combination with two highly specific sheep antisera directed against D-amphetamine and D-methamphetamine. The assay exhibits a dose response of approximately 90,000 dpm from 0 to 1000 ng/mL of D-amphetamine or D-methamphetamine with a minimum detectable dose for either drag of approximately 25 ng/mL. With a cut-off level of 500 ng/mL, the assay gave a positive result for 100% of the 111 clinical samples containing GC/MS confirmed (at or above the NIDA GC/MS cut-off values) levels of amphetamine and/or methamphetamine. Eighty eight samples that screened negative in a clinical laboratory were all negative in the assay. Nineteen samples which were incorrectly identified as positive by other commercially available amphetamine assays were negative in this RIA.

AB - A radioimmunoassay that exhibits a nearly equivalent response to D- amphetamine and D-methamphetamine in urine over the assay range of 0 to 1000 ng/mL while displaying low cross-reactivity to L-amphetamine and L- methamphetamine (4.6% and 2.4%, respectively) has been developed. In addition, methylenedioxy-amphetamine (MDA) and methylenedioxymethamphetamine (MDMA) were detectable in the assay with cross-reactivity levels of >100% and 77% respectively. Little cross-reactivity was observed with the commonly encountered over-the-counter (OTC) drags and this cross-reactivity was further reduced by the addition of sodium periodate into the reaction mixture to oxidize the β-hydroxylamines. The double (second) antibody assay uses 125I-radiolabeled derivatives of both D-amphetamine and D-methamphetamine as tracers in combination with two highly specific sheep antisera directed against D-amphetamine and D-methamphetamine. The assay exhibits a dose response of approximately 90,000 dpm from 0 to 1000 ng/mL of D-amphetamine or D-methamphetamine with a minimum detectable dose for either drag of approximately 25 ng/mL. With a cut-off level of 500 ng/mL, the assay gave a positive result for 100% of the 111 clinical samples containing GC/MS confirmed (at or above the NIDA GC/MS cut-off values) levels of amphetamine and/or methamphetamine. Eighty eight samples that screened negative in a clinical laboratory were all negative in the assay. Nineteen samples which were incorrectly identified as positive by other commercially available amphetamine assays were negative in this RIA.

KW - amphetamines

KW - detection of drugs

KW - RIA

KW - toxicology

UR - http://www.scopus.com/inward/record.url?scp=0028671837&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028671837&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 1486

EP - 1496

JO - Journal of Forensic Sciences

JF - Journal of Forensic Sciences

SN - 0022-1198

IS - 6

ER -